Predicting cardiovascular toxicity in anti-PD-1/PD-L1 therapy: a risk factor analysis and model development
Open Access
- 3 March 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1731591
Abstract
Purpose: This study aimed to investigate risk factors for cardiovascular toxicity following anti-PD-1/PD-L1 therapy and develop a predictive model. Methods: We retrospectively collected data from 2,665 patients with solid tumors treated with anti-PD-1/PD-L1 therapy at two-center between October 2018 and October 2023.We performed univariate and multivariate logistic regression to identify predictors of cardiovascular toxicity and developed a nomogram. Internal evaluation and internal validation were performed using receiver operating characteristic (ROC), decision curve analysis (DCA), calibration curve (CC) for internal evaluation and internal validation. Results: Univariate logistic regression identified the Systemic Inflammatory Response Index (SIRI;OR 2.26, 95% CI 1.19–4.27, p = 0.012), Eastern Cooperative Oncology Group performance status (ECOG;OR 9.67, 95% CI 3.04–30.69, p < 0.001), hypertension (OR 3.50, 95% CI 1.78–6.88, p < 0.001), diabetes (OR 2.52, 95% CI 1.13–5.66, p = 0.025), tumor metastasis (OR 0.17, 95% CI 0.08–0.39, p < 0.001), tumor stage (OR 0.40, 95% CI 0.21–0.76, p = 0.006), and sex (male vs. female)(OR 0.43, 95% CI 0.19–0.96, p = 0.040) as significant predictors. Multivariate analysis confirmed ECOG (OR 9.81, 95% CI 2.73–35.25, p < 0.001) and tumor metastasis (OR 0.26, 95% CI 0.10–0.71, p = 0.008) as independent predictors. Seven variables ( p < 0.05 in univariate analysis) were included in a nomogram, which showed good accuracy and discrimination (AUC 0.77, 95% CI 0.70–0.85). Conclusions: SIRI, ECOG, hypertension, diabetes, tumor metastasis, tumor stage, and sex were significant predictors of cardiovascular toxicity. ECOG was an independent risk factor, while tumor metastasis was an independent protective factor, after adjusting for other covariates. The nomogram showed good accuracy and discrimination, with clinical utility for predicting cardiovascular toxicity risk in patients receiving anti-PD-1/PD-L1 therapy.Keywords
This publication has 36 references indexed in Scilit:
- Sample size for binary logistic prediction models: Beyond events per variable criteriaStatistical Methods in Medical Research, 2018
- Myocarditis in Patients Treated With Immune Checkpoint InhibitorsJACC, 2018
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice GuidelinesEuropean Heart Journal, 2016
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153PLOS ONE, 2015
- Simple Prognostic Model for Patients With Advanced Cancer Based on Performance StatusJournal of Oncology Practice, 2014
- Estrogen and the cardiovascular systemPharmacology & Therapeutics, 2012
- Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADOEuropean Journal of Cancer, 2011
- Migration, maintenance and recall of memory T cells in peripheral tissuesNature Reviews Immunology, 2009
- T-cell homing specificity and plasticity: new concepts and future challengesTrends in Immunology, 2006
- The Protective Effects of Estrogen on the Cardiovascular SystemNew England Journal of Medicine, 1999